tiprankstipranks
Trending News
More News >
Halberd Corporation (HALB)
OTHER OTC:HALB
US Market

Halberd (HALB) Price & Analysis

Compare
53 Followers

HALB Stock Chart & Stats

$0.01
<$0.01(4.88%)
At close: 4:00 PM EST
$0.01
<$0.01(4.88%)

HALB FAQ

What was Halberd Corporation’s price range in the past 12 months?
Currently, no data Available
What is Halberd Corporation’s market cap?
Halberd Corporation’s market cap is $799.61K.
    When is Halberd Corporation’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Halberd Corporation’s earnings last quarter?
    Currently, no data Available
    Is Halberd Corporation overvalued?
    According to Wall Street analysts Halberd Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Halberd Corporation pay dividends?
      Halberd Corporation does not currently pay dividends.
      What is Halberd Corporation’s EPS estimate?
      Halberd Corporation’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Halberd Corporation have?
      Halberd Corporation has 515,874,800 shares outstanding.
        What happened to Halberd Corporation’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Halberd Corporation?
        Currently, no hedge funds are holding shares in HALB
        What is the TipRanks Smart Score and how is it calculated?
        Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

          Company Description

          Halberd Corporation

          Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
          Similar Stocks
          Company
          Price & Change
          Follow
          Scinai Immunotherapeutics
          Aditxt
          MSP Recovery
          Dermata Therapeutics
          Conduit Pharmaceuticals
          Popular Stocks